RE: AGM reviewI was also in the attendance this morning, reviews from Simon and Inforcash are pretty accurate!
I was quite surprised to see that we were only around 75 in the room! The management presentation was a recap of all we already know, including a couple on intresting slides: PP subscribers % and the 2008 schedule.
TH plans to attend to 3 major conferences in 2008:
- Endo in June (Presenting results for PIIIb)
- ???? in August (Presenting Q0L for 52 weeks)
- ???? in November (Presenting recap or both PIII trials)
Serono's appeal was turn down last January. I would like to find the blog that Rosconi was refering to.
Someone asked about the recent SP decline. He wanted to know if the decline was more related to fear surrending the January PR than the recent market conditions. Pommier and Rosconi looked at each other and seemed not very pleased to answer this question. It was pretty obvious that they would pointed out the market conditions...TH did better than the Healthcare maket during that period...ZZzzzz
Something that sounded funny to my hears. Rosconi was talking about the multiple possible options second indication, then he said he would like to do them all at the same time, but we are not yet Pfizer!!! (Moneywise of course
Andrea Gilpin told me there was less people than last year! Quite surprising
Coffee was good... Food was ok
I'm done!